SOAANZ Drug Patent Profile

✉ Email this page to a colleague

When do Soaanz patents expire, and when can generic versions of Soaanz launch?

Soaanz is a drug marketed by Sarfe Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has two patent family members in two countries.

The generic ingredient in SOAANZ is torsemide. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the torsemide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Soaanz

A generic version of SOAANZ was approved as torsemide by STRIDES PHARMA on May 27^th, 2003.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for SOAANZ?
What are the global sales for SOAANZ?
What is Average Wholesale Price for SOAANZ?

Summary for SOAANZ

International Patents:	2
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	126
Patent Applications:	4,694
Drug Prices:	Drug price information for SOAANZ
What excipients (inactive ingredients) are in SOAANZ?	SOAANZ excipients list
DailyMed Link:	SOAANZ at DailyMed

Drug patent expirations by year for SOAANZ

Pharmacology for SOAANZ

Drug Class	Loop Diuretic
Physiological Effect	Increased Diuresis at Loop of Henle

US Patents and Regulatory Information for SOAANZ

SOAANZ is protected by one US patents.

Patents protecting SOAANZ

Controlled-release formulations comprising Torsemide
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sarfe Pharms	SOAANZ	torsemide	TABLET;ORAL	213218-001	Jun 14, 2021		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Sarfe Pharms	SOAANZ	torsemide	TABLET;ORAL	213218-003	Nov 17, 2021		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sarfe Pharms	SOAANZ	torsemide	TABLET;ORAL	213218-002	Jun 14, 2021		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for SOAANZ

See the table below for patents covering SOAANZ around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	3065718	FORMULATIONS À LIBÉRATION CONTRÔLÉE COMPRENANT DU TORSÉMIDE (CONTROLLED-RELEASE FORMULATIONS COMPRISING TORSEMIDE)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2015050570		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for SOAANZ

Pharmacology for SOAANZ

Patents protecting SOAANZ

Make Better Decisions: Try a trial or see plans & pricing